Spot trading data indicates that the commodity xylene hit a latest price of 8,900.00 yuan per tonne on September 11, marking a single-day increase of 4.01%. Over the past week, the product has climbed by 9.43%, while its cumulative gain over the last month has reached an impressive 31.98%.

Xylene spot price trend: latest price of 8,900.0 on September 11, 2026, with a daily gain of +4.01%, a weekly rise of +9.43%, and a monthly surge of +31.98%. This price action is helping investors quickly identify beneficiary stocks within the sector.

Understanding the reasons behind the xylene price surge: Xylene, also known as isomeric xylene or mixed xylene, serves as a mid-stream feedstock in the aromatics industrial chain. The spot market price increase observed on September 11 can be attributed primarily to stronger international crude oil prices which elevated the cost side of the equation. This was compounded by robust demand from downstream PX producers and the gasoline market, alongside a stronger willingness among refineries and stockists to maintain firm pricing. With market supply remaining tight, spot quotations were adjusted upward accordingly.

Examining the product's industrial chain: Xylene originates from petroleum or coking crude benzene and is produced through processes such as reforming, cracking, and separation. It acts as a critical hub in the broader chemical industry chain. Downstream applications include oxidation to produce phthalic anhydride and isophthalic acid, or through disproportionation and isomerization to manufacture para-xylene. This subsequently feeds into the production of polyester fibers, plastic bottle flakes, and high-performance resins, which find extensive use across the textile, packaging, and construction materials sectors.

A note of caution: A rise in commodity prices does not necessarily correspond to equivalent gains in related individual stocks. Share prices are also influenced by factors such as company earnings, policy changes, and overall market sentiment. The above content has been compiled with the assistance of AI and is provided for reference purposes only. It does not constitute investment advice.